Data / Drug companies / Medcore LLC
Medcore LLC: 25 products in the FDA NDC directory, labeler code 82461
Medcore LLC (labeler code 82461) lists 25 products in the FDA National Drug Code Directory, covering 15 finished drugs by generic name. By type: 15 prescription drugs, 10 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 10, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82461
- Products in commercial distribution
- 25
- Packages
- 28
- Finished drugs by generic name
- 15
- Prescription products
- 15
- Over the counter products
- 10
- Flagged as original packager
- 23 of 23 products that carry the flag
- Started marketing in the last 12 months
- 16
- Earliest marketing start
- September 9, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 15 | 60% |
| Over the counter monograph drugs | 10 | 40% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 15 | 60% |
| Over the counter drugs | 10 | 40% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Benzoyl peroxide | 2 | 82 |
| Tizanidine | 2 | 38 |
| Ibuprofen | 2 | 190 |
| Lidocaine | 2 | 216 |
| Methyl salicylate | 2 | 24 |
| Capsaicin | 2 | 66 |
| Meloxicam | 2 | 54 |
| Methocarbamol | 2 | 67 |
| Cyclobenzaprine hydrochloride | 2 | 61 |
| Baclofen | 2 | 65 |
| Capsaicin 0.03% | 1 | 1 |
| Lidocaine 4% | 1 | 45 |
| Naproxen | 1 | 58 |
| Lidocaine 5% | 1 | 23 |
| Lansoprazole | 1 | 58 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 28% |
| Tablet, film coated | 6 | 24% |
| Patch | 5 | 20% |
| Cream | 4 | 16% |
| Liquid | 2 | 8% |
| Capsule, delayed release | 1 | 4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 5 |
| Amide Local Anesthetic | 4 |
| Antiarrhythmic | 4 |
| Muscle Relaxant | 4 |
| Central alpha-2 Adrenergic Agonist | 2 |
| gamma-Aminobutyric Acid-ergic Agonist | 2 |
| Proton Pump Inhibitor | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ibuprofen | 82461-725 | Tablet, film coated | Generic drugs (ANDA) | October 10, 2026 |
| Ibuprofen | 82461-724 | Tablet, film coated | Generic drugs (ANDA) | October 10, 2026 |
| Capsaicin 0.035 | 82461-421 | Patch | Over the counter monograph drugs | September 4, 2026 |
| Methocarbamol | 82461-723 | Tablet, film coated | Generic drugs (ANDA) | July 31, 2026 |
| Methocarbamol | 82461-722 | Tablet, film coated | Generic drugs (ANDA) | July 31, 2026 |
| Lidocaine 5% Cream | 82461-420 | Cream | Over the counter monograph drugs | May 4, 2026 |
| Lidocaine 4% Cream | 82461-419 | Cream | Over the counter monograph drugs | May 4, 2026 |
| Capsaicin 0.035% cream | 82461-417 | Cream | Over the counter monograph drugs | May 4, 2026 |
| Tizanidine | 82461-721 | Tablet | Generic drugs (ANDA) | April 10, 2026 |
| Tizanidine | 82461-720 | Tablet | Generic drugs (ANDA) | April 10, 2026 |
| Baclofen | 82461-718 | Tablet | Generic drugs (ANDA) | March 27, 2026 |
| Baclofen | 82461-717 | Tablet | Generic drugs (ANDA) | March 27, 2026 |
| Meloxicam | 82461-719 | Tablet | Generic drugs (ANDA) | March 25, 2026 |
| Cyclobenzaprine hydrochloride | 82461-716 | Tablet, film coated | Generic drugs (ANDA) | January 11, 2026 |
| Cyclobenzaprine hydrochloride | 82461-714 | Tablet, film coated | Generic drugs (ANDA) | January 11, 2026 |
| Lansoprazole | 82461-713 | Capsule, delayed release | Generic drugs (ANDA) | January 11, 2026 |
| Capsaicin 0.03% Patch | 82461-418 | Patch | Over the counter monograph drugs | November 1, 2025 |
| Meloxicam | 82461-712 | Tablet | Generic drugs (ANDA) | October 30, 2025 |
| Naproxen | 82461-711 | Tablet | Generic drugs (ANDA) | October 30, 2025 |
| BENZOYL PEROXIDE 10% Topical wash | 82461-313 | Liquid | Over the counter monograph drugs | October 20, 2025 |
| BENZOYL PEROXIDE 5% Topical wash | 82461-312 | Liquid | Over the counter monograph drugs | October 20, 2025 |
| Methyl Salicylate | 82461-414 | Patch | Over the counter monograph drugs | August 1, 2025 |
| Lidocaine Patch 4% | 82461-416 | Patch | Over the counter monograph drugs | May 18, 2025 |
| Methyl Salicylate 25% Cream | 82461-415 | Cream | Over the counter monograph drugs | February 14, 2025 |
| Lidocaine 5% Patch | 82461-611 | Patch | Generic drugs (ANDA) | September 9, 2024 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.